{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:55:38Z","timestamp":1781114138887,"version":"3.54.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013145","name":"Primary Research and Development Plan of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03051"],"award-info":[{"award-number":["2024C03051"]}],"id":[{"id":"10.13039\/501100013145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LHDMZ25H180001"],"award-info":[{"award-number":["LHDMZ25H180001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["CXLJ202401"],"award-info":[{"award-number":["CXLJ202401"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.critrevonc.2025.104904","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:52:40Z","timestamp":1755553960000},"page":"104904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["De Novo Malignancies Post\u2013Liver Transplantation: A Focused Review on Risks, Surveillance and Management"],"prefix":"10.1016","volume":"214","author":[{"given":"Shuqi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0846-5489","authenticated-orcid":false,"given":"Sunbin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2025.104904_bib1","article-title":"ACG clinical guidelines: colorectal cancer screening 2021","volume":"116","author":"A","year":"2021","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104904_bib2","first-page":"1428","article-title":"Risk of malignant neoplasms after liver transplantation: a population-based study","volume":"14","author":"Aberg","year":"2008","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","article-title":"Cancer mortality among recipients of Solid-Organ transplantation in ontario, Canada","volume":"2","author":"Acuna","year":"2016","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104904_bib4","doi-asserted-by":"crossref","first-page":"vi12","DOI":"10.1093\/annonc\/mdr371","article-title":"Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Aebi","year":"2011","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104904_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.12659\/AOT.901556","article-title":"Conversion from calcineurin inhibitor-based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation","volume":"22","author":"Aguiar","year":"2017","journal-title":"Ann. Transplant."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.amjmed.2018.11.005","article-title":"Effects of smoking on solid organ transplantation outcomes","volume":"132","author":"Anis","year":"2019","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib7","first-page":"250","article-title":"Time since liver transplant and immunosuppression withdrawal outcomes: systematic review and individual patient data meta-analysis","volume":"44","author":"Appenzeller-Herzog","year":"2024","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib8","first-page":"55","article-title":"Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries","volume":"42","author":"Baccarani","year":"2010","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104904_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"Journal National Comprehensive Cancer Network JNCCN"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/TP.0000000000002113","article-title":"Gender, race and disease etiology predict de novo malignancy risk after liver transplantation: insights for future individualized cancer screening guidance","volume":"103","author":"Bhat","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2025.104904_bib11","doi-asserted-by":"crossref","first-page":"102014","DOI":"10.1016\/j.trim.2024.102014","article-title":"Conversion from twice-daily everolimus to once-daily sirolimus in long-term stable liver transplant recipients","volume":"83","author":"Boillot","year":"2024","journal-title":"Transpl. immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1751-1097.2011.01043.x","article-title":"Multiple forms of DNA damage caused by UVA photoactivation of DNA 6-thioguanine","volume":"88","author":"Brem","year":"2012","journal-title":"Photochem. Photobiol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104904_bib13","article-title":"Adjuvant chemotherapy for resected early-stage non-small cell lung cancer","volume":"2015","author":"Burdett","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"29","key":"10.1016\/j.critrevonc.2025.104904_bib14","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.3748\/wjg.v21.i29.8753","article-title":"Neoplastic disease after liver transplantation: focus on de novo neoplasms","volume":"21","author":"Burra","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104904_bib15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/ajt.13018","article-title":"Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship","volume":"15","author":"Carenco","year":"2015","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104904_bib16","first-page":"1748","article-title":"Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors","volume":"35","author":"Carenco","year":"2015","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104904_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1478-3231.2010.02303.x","article-title":"Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review","volume":"30","author":"Chak","year":"2010","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jceh.2020.10.008","article-title":"Extrahepatic malignancies and liver transplantation: current status","volume":"11","author":"Choudhary","year":"2021","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104904_bib19","first-page":"242","article-title":"Very early introduction of everolimus in de novo liver transplantation: results of a multicenter, prospective, randomized trial","volume":"25","author":"Cillo","year":"2019","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib20","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003998","article-title":"De novo malignancy after liver transplantation: risk assessment, prevention, and Management\u2014Guidelines from the ILTS-SETH consensus conference","volume":"106","author":"Colmenero","year":"2022","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104904_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12906","article-title":"Why do patients die after a liver transplantation?","volume":"31","author":"Daniel","year":"2017","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.critrevonc.2025.104904_bib22","first-page":"46","article-title":"Immunosuppression in liver transplant","author":"Di Maira","year":"2020","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104904_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104904_bib24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2468-1253(19)30181-5","article-title":"Management of metabolic syndrome and cardiovascular risk after liver transplantation","volume":"4","author":"Fatourou","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104904_bib25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0000000000000555","article-title":"Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: Follow-up results from a randomized, multicenter study","volume":"99","author":"Fischer","year":"2015","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104904_bib26","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-10-2061","article-title":"Two drug interaction studies of sirolimus in combination with sorafenib or sunitinib in patients with advanced malignancies","volume":"17","author":"Gangadhar","year":"2011","journal-title":"Clinical Cancer Research Official Journal American Association Cancer Research"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4174\/astr.2015.88.4.222","article-title":"de novomalignancy after liver transplantation: a single-center experience of 14 cases","volume":"88","author":"Gao","year":"2015","journal-title":"Ann. Surg. Treat. Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104904_bib28","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1600-6143.2009.02705.x","article-title":"Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil","volume":"9","author":"Germani","year":"2009","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104904_bib29","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15253","article-title":"Systematic review with meta-analysis: Sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma","volume":"49","author":"Grigg","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104904_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12072-017-9824-z","article-title":"Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study","volume":"11","author":"Heo","year":"2017","journal-title":"Hepatol. Int."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104904_bib31","first-page":"1008","article-title":"Role of HHV-8 and mTOR pathway in post-transplant kaposi sarcoma staging","volume":"29","author":"Hern\u00e1ndez-Sierra","year":"2016","journal-title":"Transpl. Int. Off. J. Eur. Soc. Organ Transplant."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104904_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.hbpd.2024.03.001","article-title":"Advancing immunosuppression in liver transplantation: a narrative review","volume":"23","author":"Iesari","year":"2024","journal-title":"Hepatobiliary Pancreat. Dis. INT. HBPD INT"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104904_bib33","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1097\/TP.0000000000002324","article-title":"Long-term outcomes and risk factors after adult living donor liver transplantation","volume":"102","author":"Imai","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2025.104904_bib34","article-title":"Spectrum of de novo cancers and predictors in liver transplantation: analysis of the scientific registry of transplant recipients database","author":"J","year":"2016","journal-title":"PubMed"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104904_bib35","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/lt.21554","article-title":"Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study","volume":"14","author":"Jiang","year":"2008","journal-title":"Liver Transplant."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104904_bib36","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4254\/wjh.v7.i7.942","article-title":"Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis","volume":"7","author":"Jim\u00e9nez-Romero","year":"2015","journal-title":"World J. Hepatol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104904_bib37","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104904_bib38","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/TP.0b013e318288ca83","article-title":"De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study","volume":"95","author":"Kaneko","year":"2013","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1399-3046.2009.01258.x","article-title":"The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring","volume":"14","author":"Kerkar","year":"2010","journal-title":"Pediatr. Transplant."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.29485","article-title":"Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: a systematic review and meta-analysis","volume":"67","author":"Kulik","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib41","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1038\/s41467-023-43462-1","article-title":"Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like t cells","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"06","key":"10.1016\/j.critrevonc.2025.104904_bib42","first-page":"371","article-title":"Clinical analysis of de novo neoplasms in patients after liver transplantation [in Chinese","volume":"02","author":"Li","year":"2013","journal-title":"Chin. J. Hepatic Surg. (Electron. Ed. )"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104904_bib43","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/ajt.15292","article-title":"Gynecologic cancers and solid organ transplantation","volume":"19","author":"Liao","year":"2019","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104904_bib44","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.transproceed.2015.08.008","article-title":"De novo malignancies after liver transplantation with 14 cases at a single center","volume":"47","author":"Liu","year":"2015","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104904_bib46","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1600-6143.2011.03539.x","article-title":"Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success","volume":"11","author":"Lodhi","year":"2011","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American association for the study of liver diseases and the American society of transplantation: management of the successful adult liver transplant","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transplant."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104904_bib48","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/TP.0000000000000671","article-title":"Worse long-term patient survival and higher cancer rates in liver transplant recipients with a history of smoking","volume":"99","author":"Mangus","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2017.12.290","article-title":"Radiation dose-volume effects for liver SBRT","volume":"110","author":"Miften","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104904_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000468","article-title":"Guidelines for cervical cancer screening in immunosuppressed women without HIV infection","volume":"23","author":"Moscicki","year":"2019","journal-title":"J. Low. Genit. Trac. Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104904_bib51","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/ajt.12192","article-title":"De novo cancer-related death in Australian liver and cardiothoracic transplant recipients","volume":"13","author":"Na","year":"2013","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib52","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/ajt.14507","article-title":"Decreasing incidence of cancer after liver transplantation\u2014A nordic population-based study over 3 decades","volume":"18","author":"Nordin","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104904_bib53","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/17474124.2017.1355235","article-title":"Impact of liver transplantation on the risk of second malignant tumors among hepatocellular carcinoma patients","volume":"11","author":"Oweira","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib54","article-title":"De novo cancer incidence after kidney and liver transplantation: results from a nationwide population based data","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.52604\/alt.23.0006","article-title":"De novo gastric cancer after liver transplantation: a review of the asian experience","volume":"3","author":"Park","year":"2023","journal-title":"Ann. Liver Transplant."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104904_bib56","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.transproceed.2012.01.027","article-title":"De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry","volume":"44","author":"Park","year":"2012","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104904_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40262-019-00816-7","article-title":"Modelling of the time-varying pharmacokinetics of therapeutic monoclonal antibodies: a literature review","volume":"59","author":"Petitcollin","year":"2020","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104904_bib58","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/lt.24795","article-title":"The 28-year incidence of de novo malignancies after liver transplantation: a single-center analysis of risk factors and mortality in 1616 patients","volume":"23","author":"Rademacher","year":"2017","journal-title":"Liver Transplant."},{"issue":"04","key":"10.1016\/j.critrevonc.2025.104904_bib59","first-page":"165","article-title":"Analysis of de novo malignancies after liver transplantation in China: based on literature published [in Chinese]","volume":"12","author":"Rao","year":"2018","journal-title":"Chin. J. Transplant. (Electron. Ed. )"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104904_bib60","first-page":"726","article-title":"De novo malignancies after liver transplantation: clinical characteristics and management strategies [in Chinese","volume":"28","author":"Rao","year":"2022","journal-title":"Chin. J. Hepatobiliary Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104904_bib61","first-page":"445","article-title":"Factors impacting survival in those transplanted for NASH cirrhosis: data from the NailNASH consortium","volume":"21","author":"Rinella","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104904_bib62","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2012.04140.x","article-title":"Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis","volume":"12","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2012","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib63","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ijc.31769","article-title":"Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma","volume":"144","author":"Rousseau","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104904_bib64","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2006.11.021","article-title":"Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma","volume":"46","author":"Semela","year":"2007","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104904_bib65","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/lt.25310","article-title":"Longterm risk of solid organ de novo malignancies after liver transplantation: a French national study on 11,226 patients","volume":"24","author":"S\u00e9r\u00e9e","year":"2018","journal-title":"Liver Transplant."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib66","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/tri.13831","article-title":"Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation \u2013 a multicenter cohort study","volume":"34","author":"Shalaby","year":"2021","journal-title":"Transpl. Int."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104904_bib67","doi-asserted-by":"crossref","DOI":"10.5500\/wjt.v15.i3.101046","article-title":"Incidence, screening, and management of de novo malignancies in liver transplant patients: a review","volume":"15","author":"Singh","year":"2025","journal-title":"World J. Transplant."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104904_bib68","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/ijc.31552","article-title":"Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985\u20132014","volume":"143","author":"Taborelli","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104904_bib69","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/ctr.12430","article-title":"Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease","volume":"28","author":"Thimonier","year":"2014","journal-title":"Clin. Transplant."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104904_bib70","first-page":"837","article-title":"Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age","volume":"16","author":"Tjon","year":"2010","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104904_bib71","first-page":"750","article-title":"13 cases of new malignant tumors after liver transplantation [in Chinese]","volume":"36","author":"Wang","year":"2015","journal-title":"Chin. J. Organ Transplant."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104904_bib72","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Long-term probability of and mortality from de novo malignancy after liver transplantation","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104904_bib73","first-page":"616","article-title":"Second primary cancers in patients with hepatocellular carcinoma: a nationwide cohort study in Taiwan","volume":"33","author":"Wu","year":"2013","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104904_bib74","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/ijms24032101","article-title":"The role of organic cation transporters in the pharmacokinetics, pharmacodynamics and drug-drug interactions of tyrosine kinase inhibitors","volume":"24","author":"Xiu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104904_bib75","first-page":"767","article-title":"Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States","volume":"15","author":"Yang","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104904_bib76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.6002\/ect.2019.0210","article-title":"De novo malignancy after heart, kidney, and liver transplant: a nationwide study in Taiwan","volume":"18","author":"Yeh","year":"2020","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.critrevonc.2025.104904_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1465123","article-title":"Surveillance of de novo head and neck cancer in liver transplant recipients allows an early diagnosis: a retrospective analysis of a surveillance program","volume":"15","author":"Zambrano","year":"2025","journal-title":"Front. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:42:46Z","timestamp":1772880166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825002926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":77,"alternative-id":["S1040842825002926"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104904","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De Novo Malignancies Post\u2013Liver Transplantation: A Focused Review on Risks, Surveillance and Management","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104904"}}